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INTRODUCTION
Primary congenital glaucoma (PCG) is the most frequent childhood 
glaucoma and an important cause of blindness. Surgical manage-
ment of PCG is challenging because of an elevated risk of complica-
tions and failure of surgery as a result of anatomical factors related to 
ocular enlargement and aggressive healing(1).
Goniotomy and trabeculotomy are the first-line surgical inter-
ventions for PCG; however, approximately 15%-20% of PCG cases are 
refractory to these techniques(2). When angle procedures fail, more 
invasive surgeries are required to reduce the intraocular pressure (IOP), 
such as trabeculectomy or insertion of a glaucoma drainage implant(3).
Here we present an atypical case of panophthalmitis with orbital 
cellulitis following treatment with an Ahmed™ glaucoma valve (AGV) 
implant.
CASE REPORT
The patient was a 15-month-old male child who presented to the 
ophthalmologic emergency room of Hospital São Paulo with severe 
edema and erythema affecting the superior eyelid of the left eye. 
The mother had observed moderate hyperemia and purulent eye 
discharge associated with prostration and low fever over a period of 
2 days previously. Examination was limited due to a lack of coopera-
tion. Routine ophthalmological evaluation performed a week earlier 
had been unremarkable. 
According to the parents, the patient had a history of blepharos-
pasm, epiphora, and photophobia in both eyes since birth and had 
been diagnosed with PCG at 2 months of age. All information related 
to previous ophthalmological history was collected from medical re-
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Initial examination under anesthesia revealed buphthalmos [axial 
length: 22.43 mm, oculus dexter (OD); 23.99 mm, oculus sinister (OS)], 
corneal enlargement [13 mm, oculus uterque (OU)] with important 
haze and an elevated IOP (OD: 24 mmHg/OS: 28 mmHg). Trabeculo-
tomy was subsequently performed on both eyes. 
In order to manage IOP during the first year, other surgeries were 
attempted on both eyes, including trabeculotomy (OS), combined 
trabeculotomy and trabeculectomy (OD), and trabeculectomy (OU). 
All surgeries were uneventful.
One month prior to this presentation to the emergency room, 
the patient presented with bilateral increases in axial length (OD, 
28.60 mm; OS, 28.76 mm) and an elevated IOP. No filtration bleb was 
observed in the OS during ophthalmological examination under 
anesthesia. Subsequently, uneventful AGV implantation was perfor-
med (FP7 model, New World Medical Inc., Rancho Cucamonga, CA). 
The parents stated that moxifloxacin 0.5% (4 times/day for 10 days) 
and prednisolone acetate 1% (5 times/day for 4 weeks) had been 
adequately instilled in the OS during the postoperative period.
Prompt hospitalization was recommended in light of the initial 
pediatric examination. Blood samples were collected for culture and 
empirical intravenous antibiotic treatment with vancomycin (60 mg/kg/ 
day) and cefepime (150 mg/kg/day) was initiated. Computed tomo-
graphy of the orbit and ocular ultrasonography were performed. 
Computed tomography suggested infiltration of the periorbitary 
tissue, generalized scleral thickening, and increased density of the 
postseptal fat (Figure 1). Ultrasonography findings included low-am-
plitude mobile echoes, vitreous membranes, and thickening of the 
retina and choroid (Figure 2).
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DISCUSSION
Satisfactory success rates with the AGV to control IOP in pediatric 
glaucoma have been reported(3). Infectious events in patients treated 
with glaucoma drainage implants are rare. In 2 long-term studies 
comparing outcomes following the use of Ahmed™ and Baerveldt™ 
glaucoma devices, the incidence of endophthalmitis in adult patients 
was 0.8% and 2%, respectively, with no significant difference obser-
ved between implants(4,5). 
There have been few reports describing similar complications in 
childhood glaucoma. A retrospective review of patients treated with 
AGVs by Al-Torbak et al. reported endophthalmitis in 4.4% of children 
(5/113 eyes) and 0.9% (4/429 eyes) of adults(6). The time course for the 
development of endophthalmitis ranged from 4 weeks to 12 months, 
with a median time of 7 months postoperatively(7).
Lack of compliance with postoperative care recommendations, 
including the avoidance of eye rubbing and non-adherence to to-
pical treatments, may increase the risk of early infection in children. 
Generally, incisions heal insufficiently during the first postoperative 
month and conjunctival dehiscence allows ocular infiltration of bac-
terial agents through the ocular surface(8).
The most frequently isolated organisms in cases of endophthal-
mitis following the insertion of glaucoma drainage implants in chil-
dren are Haemophilus influenzae, Streptococcus pneumoniae, or both. 
These organisms are components of the normal bacterial flora of the 
conjunctiva and upper respiratory tract(8). Orbital cellulitis in children 
is typically secondary to sinusitis, with Staphylococcus aureus and 
Streptococcus pyogenes isolated in 75% of cases(9).
S. epidermidis is capable of forming biofilms, a characteristic of 
bacteria highly resistant to antibiotic treatment and found on the 
surface of prosthetic medical devices. The formation of biofilms has 
reportedly been observed on intraocular lenses, scleral buckles, cor-
neal sutures, stents, and glaucoma tubes(10). 
Antibiotic regimens are typically initiated with broad-spectrum 
agents to cover gram-positive and gram-negative organisms known 
to cause postoperative endophthalmitis. In a retrospective study, Miller 
et al. demonstrated that 100% of the S. epidermidis strains isolated 
from vitreous samples were sensitive to vancomycin and 68% were 
sensitive to fourth-generation fluoroquinolones(11). 
The recommendation of removing glaucoma shunt devices from 
eyes with endophthalmitis is controversial(6,12). In the present case, we 
decided to remove the AGV due to the presence of purulent material 
surrounding the plate. The prognosis of endophthalmitis ranges from 
recovery to previous visual acuity to progression to phthisis bulbi.
Figure 1. Orbital computed tomography demonstrated proptosis, 
inflammation of the extraconal fat, scleral thickening, and diffuse 
purulent collection surrounding the Ahmed™ glaucoma valve 
implant (arrow).
Figure 2. B-scan ultrasonography demonstrated vitreous opacities. 
Figure 3. Clinical progression after glaucoma drainage device removal and antibiotic 
therapy, showing the regression of the eyelid edema. A) At presentation. B) One day 
postoperatively. C and D) Two days postoperatively. E) Seven days postoperatively. F) 
Fifteen days postoperatively.
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The patient was examined under anesthesia on the same day. 
Perioperative observations revealed a swollen, tense, and hyperemic 
superior eyelid. The OS was proptotic. The conjunctiva was chemotic 
and had significant hyperemia (3+/4), the cornea was diffusely hazy, 
and the anterior chamber had a large hypopyon. Neither the lens nor 
the ocular fundus could be visualized. 
The previous surgical site was explored. Purulent material sur-
rounding the valve was observed. The plate was removed and sent for 
bacterial culture analysis. Abundant irrigation with balanced saline 
solution was performed. A 30-gauge needle was introduced through 
the pars plana and a 0.3-ml specimen was obtained from the vitreous 
and used to directly inoculate culture media. Vancomycin (2.5 mg/0.1 ml) 
and ceftazidime (2.5 mg/0.1 ml) were injected intravitreally and into 
the subtenon space.
Although repeated cultures from blood and vitreous samples 
were negative, cultures from the removed tube revealed infection 
with Staphylococcus epidermidis sensitive to amikacin, cefalotin, line-
zolid, rifampicin, and vancomycin.
The patient completed 8 days of treatment with intravenous van-
comycin and cefepime during the hospital stay, topical gatifloxacin 5 
times/day for 2 weeks, and 10 days of treatment with oral amoxicilin/
clavulanate potassium at home. Complete regression of eyelid ede-
ma was observed after 15 days of treatment (Figure 3). Unfortunately, 
the OS subsequently progressed to phthisis bulbi. 
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Severe infections, such as orbital cellulitis, in pediatric cases re-
quire prompt hospitalization and initiation of intravenous antibiotic 
treatment because of the risk of posterior spread into the cavernous 
sinus. Parents should be informed of all surgical risks, complications, 
and warning signs to allow for early evaluation. Postoperative infec-
tious events with prosthetic materials should be communicated to 
hospital infection committees and device manufacturers.
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